Introduction
In clinical practice, the assessment of glomerular function or overall renal function in patients thought or known to have chronic renal disease is based on some measure of glomerular filtration rate (GFR).
It is generally accepted that gross reduction in glomerular function can be detected by measuring plasma creatinine alone. However, Tobias, McLaughlin and Hopper (1962) and Doolan, Alpen and Theil (1962) concluded that in the detection of smaller reductions of glomerular function, creatinine clearance had worthwhile advantages over the much simpler measurement of plasma creatinine, and this view has generally persisted. The authors have reconsidered the arguments and assessed the quality of the information obtained about glomerular function with the two measures, creatinine clearance and plasma creatinine. Their major conclusion is that the routine measurement of endogenous creatinine clearance should be abandoned and efforts should be concentrated on improving the information which can be obtained from the measurement of plasma The more usual questions are whether glomerular function is abnormal, to what extent it is abnormal, and whether it has changed. In practice a patient's value in health is usually not known so that the presence of abnormality and its extent have to be assessed by comparing his value for the chosen test with the appropriate reference range. The reliability of the decisions about normality or change of glomerular function also depends on the reproducibility of the measurement, that is, the variability in the test result in the absence of a real change. Thus the problems of reference ranges and of reproducibility are important aspects of the assessment of glomerular function.
The tests of glomerular function Four tests are used to assess glomerular function; plasma urea, plasma creatinine, endogenous creatinine clearance and the clearance of an injected compound such as inulin or 51Cr-EDTA. Inulin and 5'Cr-EDTA clearance give a more accurate assessment of GFR than does creatinine clearance because of the tubular secretion of creatinine (Materson, 1971) . However, these techniques are more complex and less freely available than creatinine clearance and, although they give more accurate and precise information, the problems of interpretation are the same as with creatinine clearance.
At the other extreme, the simple and readily available measurement of plasma urea is influenced by several factors other than changes in glomerular function, such as changes in protein intake and in urine flow rate, which do not significantly affect plasma creatinine (Kassirer, 1971; Kerr and Davidson, 1975) . A study by the authors has shown a very wide range of relations between plasma urea and plasma creatinine concentrations in a sequential series of hospital patients.
Plasma creatinine is becoming increasingly available on a same day or even an emergency basis and there can be little doubt that it should replace urea as the screening procedure for renal failure. The question which remains is whether, in routine clinical practice, creatinine clearance has clear-cut advantages over plasma creatinine for the detection of abnormal glomerular function and of changes in glomerular function. The choice will depend not only on the physiological relation between plasma creatinine and creatinine clearance but also on the quality of the available reference ranges and the reproducibility of the measurements.
The relation between plasma creatinine and creatinine clearance Plasma creatinine concentration (P) is determined by the creatinine production rate and by the creatinine clearance (Ccr). In the steady state, creatinine production rate and excretion rate are equal (Payne and Morgan, 1977) and can be measured as the product of urine creatinine concentration and urine volume per unit time (U.V). But Ccr equals U.V/P so that P equals U.V/Ccr. Plasma creatinine (P) therefore increases as creatinine production (U.V) increases or creatinine clearance (Ccr) decreases. It follows that in an individual with a constant rate of creatinine production (U.V), P will vary as the reciprocal of Ccr. Any reduction of creatinine clearance in an individual is associated with an increase in P, and the rate of increase will accelerate as GFR falls progressively; a halving of Ccr will cause a doubling of P. Figure 1 shows the relation between P and Ccr as (mg/ /100 ml ) ('4mol (Cook, 1975 Plasma creatinine has been measured in large groups of apparently well persons, but few studies have examined the changes with age in detail. Figure 2 shows that the average value for P increases through childhood to reach adult values by about the age of 20 years (Kuhlback, Eriksson and Forsius, 1964; Donckerwolcke et al., 1970; Schwartz et al., 1976) . In studies of large numbers of apparently healthy adults the P increases by only a few per cent between 20 and 80 years (Kuhlback et al., 1964; Wilding, Rollason and Robinson, 1972; de Lauture et al., 1973) . The range of values is about the same at all ages. Rowe et al. (1976) Ezmol/l and the P in the remaining patients did not change with age (Fig. 2) . In these two studies (Kampmann et al., 1971; Rowe et al., 1976) , the frequency of exclusion increased markedly with age indicating that the prevalence of renal disease increased with age. Cockroft and Gault (1976) studied the plasma creatinine in hospital patients who had had their creatinine clearance measured for diagnostic reasons. The P in these patients increased with age presumably because of the inclusion of patients with renal disease the prevalence or which increases with age, if one takes into account hypertensive vascular disease.
The results taken together suggest that in the healthy population there is little increase in the average P with age. However, the frequency of renal disease increases with age so that, in unselected patients in hospitals, the average P increases with age.
The relation between P and age is similar in women to that in men but the values in adult women are about 10% lower than those in men at all ages (Table 1) . This is about the same as the percentage difference in lean body mass between men and women, so that the average ratio of P to lean body mass is about the same in men and women (Doolan et al., 1962) . However, it has not been shown that there is a relation between P and lean body mass within a group of men and women.
There have been three studies of the relation between Ccr and age (Cockroft and Gault, 1976; Kampmann et aL., 1971; Rowe et al., 1976) . Figure 3 shows that in these studies Ccr in men falls by as much as 50%/ between the ages of 20 and 70 years.
In two of these studies, men with renal disease were excluded (Kampmann et aL., 1971; Rowe et al., 1976) . In the third study (Cockroft and Gault, 1976) , the men were being investigated for renal disease, and the Ccr was lower than in the other two studies, particularly in the older men where uro-genital disease is most common. The percentage fall with age is about the same in women as in men (Kampmann et al., 1971) . The results taken together suggest that there is a progressive reduction in Ccr (glomerular function) with age even in the patients without clearcut evidence of renal disease whose P does not increase with age ( Fig. 3 ). The constancy of P in the face of a fall in Ccr is explained by a fall in creatinine production (U.V) which is proportionally similar to the fall in Ccr (Fig. 4) . Rowe et al. 1976. It is generally assumed that there is a relation between creatinine clearance and body size, but this relationship has not been defined in detail in adults. (Table 3) . The total within-person variability is not much greater than the analytical. There is no significant diurnal variation of P in health (Sratland, Winkel and Bokelund, 1973a) , no difference between fasting values and those after a meal, and only a small increase after even very strenuous exercise (Statland et al., 1973b) . If analytical error is the same for urine as it is for plasma and one assumes no error in the urine collection, then the analytical coefficient of variation (Doolan et al., 1962; Paterson, 1967; Cramer, Cramer and Selander, 1967) . The coefficient of variation of Ccr within a person, including analytical and biological variation, is at least 15% ( (Edwards and Whyte, 1959; Doolan et al., 1962; Enger and Blegen, 1964; Jelliffe, 1971 (Haugen and Blegen, 1935) .
The second objection is that the P is insensitive and of limited use in practice because it does not become abnormal until the glomerular function falls to 25% of normal or less. This conclusion is based on reports such as those of Tobias et al. (1962) and Doolan et al. (1962) which demonstrate relationships between P and Ccr similar to that shown in Fig. 1 . The data have been interpreted in terms of the value of Ccr at which the average P reaches the upper limit of normal for P. But the wide range of Ccr associated with a P at the upper limit of normal was due in part to the inclusion of older persons who have lower Ccr without a higher P (Figs 2 and 3) . For persons of a given age, e.g. young men, the P is more sensitive to reduction in Ccr, in that the average P reaches the upper limit of normal at a Ccr which is 75%o of normal. However, amongst these young men there will be individuals whose usual value for P is at the upper limit of normal and whose P will become abnormal as soon as the Ccr falls. Other individuals whose usual P is at the bottom of the liormal range will not have a P above the normal range until the Ccr has fallen to 50% of normal. This lack of sensitivity in the detection of abnormality is present in any situation where one is comparing a patient's value with a reference range rather than with his value when he was healthy. The limitation applies to the Ccr itself since, if one takes the range in Table 2 , an individual with a value at the top of the range to begin with would not have an abnormally low Ccr until he had lost 60% of his original glomerular function.
It is the third objection that Ccr may be low when the P is normal which casts most doubt on the usefulness of the P. The work of Doolan et al. (1962) and Tobias et al. (1962) that is, there will also be patients with a raised P whose Ccr has fallen, but is still within the normal range. Indeed, among the 102 patients of Doolan et al. (1962) who had P and Ccr measured, both measures were normal in forty-five, both were abnormal in forty-two, Ccr alone was abnormal in three, but P alone was abnormal in twelve. Tobias et al. (1962) also emphasize that some patients have a low Ccr with a normal P and they give details of five such patients. But it is clear from their Fig. 1 that there were patients with a raised P and a normal Ccr. A disturbing aspect of the paper of Tobias and his colleagues (1962) is that they excluded clearances where the 'urinary output ... was suspiciously low'.
In order to assess the relative sensitivity of P and Ccr in the detection of abnormal glomerular function the authors have taken the situation of a group of young men with the reference values of P and Ccr given in Table 3 and calculated the distribution of P and Ccr as Ccr progressively decreased. The plasma creatinine at each Ccr was calculated assuming a constant U.V (details of the calculation are given in Appendix II). Figure 5 shows the calculated frequency of persons with abnormal values for P and Ccr at each new average value of Ccr. The P is clearly a more sensitive detector of abnormality of glomerular function. The individuals identified as abnormal differed for the two measures depending on where the initial value lay within the reference range. However, as Fig. 5 shows, only a small number of patients had an abnormal Ccr without an abnormal P. The calculations have been repeated on the basis of triplicate measurements of P and Ccr.
The P was still more sensitive than the Ccr (Fig. 5) .
The diagnostic usefulness of the Ccr is further limited if patients of all ages are included since, unlike P, the Ccr changes with age and the reference ranges according to age have not been adequately defined. Alternative measures to Ccr, such as the clearance of 51Cr-EDTA are more reproducible (Br6chner-Morter.sen and R6dbro, 1976) but still have the disadvantage that efficient use requires age specific reference ranges. The present advantage of these alternatives over P, if any, will depend on their reproducibility in routine practice and the age distribution of the population which is being investigated. Indeed, if the reference range for young persons is applied to a hospital population most of the abnormal values for Ccr will be due to the fall in Ccr with age, and not due to renal disease.
The authors suggest, therefore, that none of the three arguments for Ccr and against P as the detector of abnormal glomerular function is valid and that, for several reasons, P is to be preferred. Ccr which might be observed in a man whose set values in health were 1 0 mg/100 ml (88 mol/l) and 120 ml/min respectively and whose set value for Ccr progressively decreased. The values for P have been calculated from the values for Ccr, assuming that U.V is constant (details of the calculation are given in Appendix II). Figure 6 shows the frequency of significantly raised P and lowered Ccr at each value of Ccr. The change is detected more frequently with P than with Ccr and this is the case even when the calculations are based on triplicate measurements of P and Ccr (Fig. 6) . P is therefore more sensitive than Ccr in the detection of change in glomerular function.
However, creatinine clearance does have the advantage that it changes in the direction of and in proportion to the changes in GFR, whereas P does not (Fig. 1) . These advantages can be given to P by calculating its reciprocal. The reciprocal of P (,umol/l) multiplied by 104 has the same magnitude as Ccr (ml/min). Creatinine excretion is said to decrease in severe renal failure which would apparently make P (or its reciprocal) unreliable assessments of the progress of the renal failure. However, this decrease is small and the reciprocal of P continues to decrease linearly with time in individual patients even as renal failure becomes terminal (Mitch et al., 1976; Rutherford et al., 1977) .
Conclusion
The authors suggest that, in order to assess a patient's glomerular function, one does not really need to know the GFR but rather whether the GFR is appropriate for the patient's age and physique, and thus whether he is able to maintain his internal environment within acceptable limits. This information is provided by the plasma creatinine. It is true that a reduction in glomerular function can happen without the P becoming abnormal (i.e. outside the normal range) but this happens even more frequently for Ccr, and deterioration in glomerular function is detected less frequently with Ccr than with P. The reciprocal of plasma creatinine has the further advantages that it changes in the same direction as, and in proportion to, the changes in glomerular function. The authors believe the routine measurement of Ccr should be abandoned, and efforts should be directed to narrowing the reference ranges for P by taking account of body size and composition. These efforts are already being made in paediatrics (Counahan et al., 1976 (Campbell and Owen, 1967; Payne, 1972) .
If one includes all sources of error ( (a) Detection ofabnormal glomerular function TI Ihe calculations were based on a group of young men with the mean and range of P and Ccr shown in Table 3 . The distribution of each variable was assumed to be Gaussian. The mean Ccr was then reduced by 10 ml/min (s.d. unchanged), the U.V was kept constant and the mean and s.d. of the 'new' P were calculated. Abnormal values of Ccr were taken as values below the 95% limit of the original distribution and abnormal values for P were taken as values above the 95%/ limit of the original distribution. In order to calculate the frequency (%Y) of abnormal values of P and Ccr when the Ccr was reduced by 10 ml/min, the position of the limit of normality within the new distribution of values was defined in terms of deviation from the mean in standard deviation units. The percentage of the population outside this limit of the distribution was obtained from tables. These calculations were repeated for progressive reduction in Ccr.
In order to enable the comparison on the basis of the mean of triplicate measurements it was assumed that the standard deviation of the within-person variability would be reduced by a factor of /3. The s.d. of the distribution in the group of young men was calculated on this basis.
(b) Detection of change This calculation was based on a man with the set values for P and Ccr which were the means of the reference population of young men (Table 3) . Even if there was no real change in the set value the observed values of P and Ccr could vary from time to time within distributions with the within-person standard deviations shown in Table 3 . The true Ccr of this man was reduced by 10 ml/min. The new within-person variation was calculated assuming that the analytical coefficient of variation was unchanged. The new set value for P was calculated on the assumption that the U.V was unchanged. The within-person variability around this set value was calculated on the basis that the within-person coefficient of variation had not changed. The distribution of differences between single values from the original and new distributions was calculated.
The percentage of this distribution of differences with values greater than twice the standard deviation of the difference was calculated. These calculations were repeated for progressive decreases of Ccr, and on the basis of the mean of triplicate measurements of P and Ccr.
